annual accounts payable:
$4.01B+$211.09M(+5.56%)Summary
- As of today (September 10, 2025), NVO annual accounts payable is $4.01 billion, with the most recent change of +$211.09 million (+5.56%) on December 31, 2024.
- During the last 3 years, NVO annual accounts payable has risen by +$2.65 billion (+195.34%).
- NVO annual accounts payable is now at all-time high.
Performance
NVO Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$4.44B+$1.60B(+56.57%)Summary
- As of today (September 10, 2025), NVO quarterly accounts payable is $4.44 billion, with the most recent change of +$1.60 billion (+56.57%) on June 1, 2025.
- Over the past year, NVO quarterly accounts payable has increased by +$161.01 million (+3.76%).
- NVO quarterly accounts payable is now at all-time high.
Performance
NVO quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NVO Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.6% | +3.8% |
| 3 y3 years | +195.3% | +115.4% |
| 5 y5 years | +319.4% | +228.6% |
NVO Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +195.3% | at high | +305.3% |
| 5 y | 5-year | at high | +326.2% | at high | +372.2% |
| alltime | all time | at high | +4637.0% | at high | +5104.6% |
NVO Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $4.44B(+56.6%) |
| Mar 2025 | - | $2.83B(-29.2%) |
| Dec 2024 | $4.01B(+5.6%) | $4.01B(+11.1%) |
| Sep 2024 | - | $3.60B(-15.7%) |
| Jun 2024 | - | $4.28B(+127.1%) |
| Mar 2024 | - | $1.88B(-50.4%) |
| Dec 2023 | $3.79B(+69.6%) | $3.79B(+32.9%) |
| Sep 2023 | - | $2.85B(+9.5%) |
| Jun 2023 | - | $2.61B(+77.8%) |
| Mar 2023 | - | $1.47B(-34.5%) |
| Dec 2022 | $2.24B(+64.9%) | $2.24B(+104.3%) |
| Sep 2022 | - | $1.09B(-46.9%) |
| Jun 2022 | - | $2.06B(+106.2%) |
| Mar 2022 | - | $999.05M(-26.3%) |
| Dec 2021 | $1.36B(+44.3%) | $1.36B(-2.0%) |
| Sep 2021 | - | $1.38B(+13.9%) |
| Jun 2021 | - | $1.21B(+13.0%) |
| Mar 2021 | - | $1.07B(+14.3%) |
| Dec 2020 | $939.76M(-1.6%) | $939.76M(-2.6%) |
| Sep 2020 | - | $964.59M(-28.6%) |
| Jun 2020 | - | $1.35B(+71.8%) |
| Mar 2020 | - | $785.79M(-17.7%) |
| Dec 2019 | $955.08M(-7.7%) | $955.08M(+11.0%) |
| Sep 2019 | - | $860.62M(+7.1%) |
| Jun 2019 | - | $803.94M(+26.6%) |
| Mar 2019 | - | $635.02M(-38.6%) |
| Dec 2018 | $1.03B(+14.4%) | $1.03B(+37.1%) |
| Sep 2018 | - | $754.79M(-17.4%) |
| Jun 2018 | - | $913.58M(+34.5%) |
| Mar 2018 | - | $679.27M(-24.9%) |
| Dec 2017 | $904.78M(+6.1%) | $904.78M(+25.7%) |
| Sep 2017 | - | $719.64M(+10.2%) |
| Jun 2017 | - | $653.03M(+20.1%) |
| Mar 2017 | - | $543.96M(-36.2%) |
| Dec 2016 | $852.68M(+18.9%) | $852.68M(+26.6%) |
| Sep 2016 | - | $673.41M(-15.4%) |
| Jun 2016 | - | $796.35M(+39.2%) |
| Mar 2016 | - | $572.04M(-20.2%) |
| Dec 2015 | $717.20M(-10.8%) | $717.20M(+24.7%) |
| Sep 2015 | - | $575.32M(-2.0%) |
| Jun 2015 | - | $587.28M(+1.8%) |
| Mar 2015 | - | $577.06M(-28.3%) |
| Dec 2014 | $804.39M(+6.4%) | $804.39M(+58.6%) |
| Sep 2014 | - | $507.07M(-7.6%) |
| Jun 2014 | - | $548.74M(-14.8%) |
| Mar 2014 | - | $644.27M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $755.80M(+10.8%) | $755.80M(+42.1%) |
| Sep 2013 | - | $531.98M(+5.2%) |
| Jun 2013 | - | $505.56M(-4.7%) |
| Mar 2013 | - | $530.36M(-22.2%) |
| Dec 2012 | $681.91M(+18.6%) | $681.91M(+46.9%) |
| Sep 2012 | - | $464.05M(+2.9%) |
| Jun 2012 | - | $450.99M(-1.6%) |
| Mar 2012 | - | $458.24M(-20.3%) |
| Dec 2011 | $574.81M(+9.9%) | $574.81M(+38.6%) |
| Sep 2011 | - | $414.71M(-19.9%) |
| Jun 2011 | - | $517.44M(-3.7%) |
| Mar 2011 | - | $537.10M(+2.7%) |
| Dec 2010 | $523.15M(+21.0%) | $523.15M(+42.4%) |
| Sep 2010 | - | $367.30M(-5.2%) |
| Jun 2010 | - | $387.25M(+8.8%) |
| Mar 2010 | - | $356.06M(-17.6%) |
| Dec 2009 | $432.30M(+1.5%) | $432.30M(+43.3%) |
| Sep 2009 | - | $301.78M(-3.5%) |
| Jun 2009 | - | $312.66M(+0.6%) |
| Mar 2009 | - | $310.88M(-27.0%) |
| Dec 2008 | $425.98M(+11.6%) | $425.98M(+49.0%) |
| Sep 2008 | - | $285.97M(-16.0%) |
| Jun 2008 | - | $340.34M(+2.0%) |
| Mar 2008 | - | $333.60M(-12.6%) |
| Dec 2007 | $381.76M(+26.1%) | $381.76M(+32.5%) |
| Sep 2007 | - | $288.09M(-0.6%) |
| Jun 2007 | - | $289.83M(+7.8%) |
| Mar 2007 | - | $268.87M(-11.2%) |
| Dec 2006 | $302.84M(+27.7%) | $302.84M(+27.7%) |
| Dec 2005 | $237.21M(+22.4%) | $237.21M(+22.4%) |
| Dec 2004 | $193.88M(+13.5%) | $193.88M(+13.5%) |
| Dec 2003 | $170.76M(+39.9%) | $170.76M(+39.9%) |
| Dec 2002 | $122.06M(+5.1%) | $122.06M(+5.1%) |
| Dec 2001 | $116.16M(-5.5%) | $116.16M(-5.5%) |
| Dec 2000 | $122.89M(-9.1%) | $122.89M(+13.0%) |
| Dec 1999 | $135.23M(+12.1%) | $108.76M(-9.9%) |
| Dec 1998 | $120.67M(+42.7%) | $120.71M(+41.6%) |
| Dec 1997 | $84.56M(-36.1%) | $85.27M(-35.2%) |
| Dec 1996 | $132.23M(-16.0%) | $131.50M(-73.2%) |
| Dec 1995 | $157.34M(-7.8%) | $490.40M(+189.8%) |
| Dec 1994 | $170.73M(+25.0%) | $169.24M(+23.6%) |
| Dec 1993 | $136.58M(-14.1%) | $136.90M(-60.2%) |
| Dec 1992 | $159.07M(+27.2%) | $344.33M(+175.2%) |
| Dec 1991 | $125.06M(+10.6%) | $125.10M(+10.7%) |
| Dec 1990 | $113.06M(+26.0%) | $112.98M |
| Dec 1989 | $89.71M | - |
FAQ
- What is Novo Nordisk A/S annual accounts payable?
- What is the all time high annual accounts payable for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual accounts payable year-on-year change?
- What is Novo Nordisk A/S quarterly accounts payable?
- What is the all time high quarterly accounts payable for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly accounts payable year-on-year change?
What is Novo Nordisk A/S annual accounts payable?
The current annual accounts payable of NVO is $4.01B
What is the all time high annual accounts payable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual accounts payable is $4.01B
What is Novo Nordisk A/S annual accounts payable year-on-year change?
Over the past year, NVO annual accounts payable has changed by +$211.09M (+5.56%)
What is Novo Nordisk A/S quarterly accounts payable?
The current quarterly accounts payable of NVO is $4.44B
What is the all time high quarterly accounts payable for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly accounts payable is $4.44B
What is Novo Nordisk A/S quarterly accounts payable year-on-year change?
Over the past year, NVO quarterly accounts payable has changed by +$161.01M (+3.76%)